---
title: "Haemonetics (HAE) Receives a Hold from Citi"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295785638.md"
description: "Citi analyst Joanne Wuensch maintained a Hold rating on Haemonetics (HAE) with a $92 price target. This follows mixed sentiment, including a Buy rating from Bank of America Securities and a Hold from J.P. Morgan."
datetime: "2026-08-13T10:57:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295785638.md)
  - [en](https://longbridge.com/en/news/295785638.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295785638.md)
---

# Haemonetics (HAE) Receives a Hold from Citi

In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Haemonetics, with a price target of $92.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Wuensch is a 4-star analyst with an average return of 2.5% and a 54.64% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Baxter International, and Edwards Lifesciences.

In addition to Citi, Haemonetics also received a Hold from J.P. Morgan’s Allen Gong in a report issued on August 10. However, yesterday, Bank of America Securities assigned a Buy rating to Haemonetics (NYSE: HAE).

### Related Stocks

- [HAE.US](https://longbridge.com/en/quote/HAE.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [BAX.US](https://longbridge.com/en/quote/BAX.US.md)
- [EW.US](https://longbridge.com/en/quote/EW.US.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)
- [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md)
- [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md)
- [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md)
- [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md)
- [8634.JP](https://longbridge.com/en/quote/8634.JP.md)
- [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md)
- [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [Is Haemonetics’ (HAE) ESOP Shelf Move Reframing Its Balance Between Growth Investment and Shareholder Dilution?](https://longbridge.com/en/news/296298828.md)
- [Assenagon Asset Management S.A. Sells 142,292 Shares of Haemonetics Corporation $HAE](https://longbridge.com/en/news/295894631.md)
- [Haemonetics: CSL Plasma Migration Deal Highlights Long-Term Upside but Near-Term Risk/Reward Keeps Rating at Hold](https://longbridge.com/en/news/296243457.md)
- [Jefferies Reaffirms Their Hold Rating on Cosan S.A. (CSAN3)](https://longbridge.com/en/news/295881930.md)
- [J.P. Morgan Reaffirms Their Hold Rating on Pennantpark Investment (PNNT)](https://longbridge.com/en/news/296176376.md)